Review of Metabolomics-Based Biomarker Research for Parkinson’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of Metabolomics-Based Biomarker Research for Parkinson’s Disease
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume 59, Issue 2, Pages 1041-1057
Publisher
Springer Science and Business Media LLC
Online
2021-11-26
DOI
10.1007/s12035-021-02657-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
- (2021) Yaping Shao et al. Molecular Neurodegeneration
- Sporadic Parkinson’s Disease Potential Risk Loci Identified in Han Ancestry of Chinese Mainland
- (2021) Bo Wang et al. Frontiers in Aging Neuroscience
- Brain Metabolite, N-Acetylaspartate Is a Potent Protein Aggregation Inhibitor
- (2021) Marina Warepam et al. Frontiers in Cellular Neuroscience
- Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
- (2021) Vinod Metta et al. JOURNAL OF NEUROLOGY
- Challenges in the diagnosis of Parkinson's disease
- (2021) Eduardo Tolosa et al. LANCET NEUROLOGY
- Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
- (2021) Justyna Okarmus et al. Stem Cell Reports
- Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
- (2021) Agata Mulak JOURNAL OF ALZHEIMERS DISEASE
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Implications of the Gut Microbiome in Parkinson's Disease
- (2020) Mohamed Elfil et al. MOVEMENT DISORDERS
- Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson’s disease and healthy controls
- (2020) Sadhana Kumari et al. NEUROLOGICAL SCIENCES
- The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
- (2020) Anne-Laure Mahul-Mellier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control Study
- (2020) Maya R. Silver et al. Journal of Parkinsons Disease
- GC-MS Based Metabolic Profiling of Parkinson’s Disease with Glutathione S-transferase M1 and T1 Polymorphism in Tunisian Patients
- (2020) Amal Rebai et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson’s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study
- (2020) Riccardo Calvani et al. GeroScience
- Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
- (2020) Chiara Villa et al. Journal of Personalized Medicine
- Status and perspectives of biomarker validation for diagnosis, stratification, and treatment
- (2020) J. Skov et al. PUBLIC HEALTH
- Parkinson's Disease and the Environment
- (2019) Nicole Ball et al. Frontiers in Neurology
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
- (2019) Alan Whone et al. BRAIN
- Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
- (2019) Connie Marras et al. MOVEMENT DISORDERS
- Updates and advances in the treatment of Parkinson disease
- (2019) Michael W Hayes et al. MEDICAL JOURNAL OF AUSTRALIA
- A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study
- (2019) Jacopo Troisi et al. Metabolomics
- Diagnosis and Differential Diagnosis of Parkinson Disease
- (2019) Stefano Caproni et al. CLINICS IN GERIATRIC MEDICINE
- The Need for Multi-Omics Biomarker Signatures in Precision Medicine
- (2019) Michael Olivier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The genetic architecture of Parkinson's disease
- (2019) Cornelis Blauwendraat et al. LANCET NEUROLOGY
- The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
- (2019) Shirley Yin-Yu Pang et al. Translational Neurodegeneration
- Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease
- (2019) Xiaojia Ren et al. FREE RADICAL BIOLOGY AND MEDICINE
- Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study
- (2019) Anna Picca et al. EXPERIMENTAL GERONTOLOGY
- Genetic risk factors in Parkinson’s disease
- (2018) K. J. Billingsley et al. CELL AND TISSUE RESEARCH
- Alzheimer's disease in the omics era
- (2018) Giulia M. Sancesario et al. CLINICAL BIOCHEMISTRY
- Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
- (2018) Huiyuan Zhao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
- (2018) Daniel Stoessel et al. Frontiers in Aging Neuroscience
- Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
- (2018) Joseph Jankovic et al. JAMA Neurology
- Application of Metabolomics in Alzheimer’s Disease
- (2018) Jordan Maximillian Wilkins et al. Frontiers in Neurology
- The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis
- (2018) Feng zhu et al. DIGESTIVE AND LIVER DISEASE
- Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
- (2018) Ilaria Cova et al. JOURNAL OF NEURAL TRANSMISSION
- Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women
- (2018) Natalia Palacios et al. MOVEMENT DISORDERS
- Validation of the MDS clinical diagnostic criteria for Parkinson's disease
- (2018) Ronald B. Postuma et al. MOVEMENT DISORDERS
- The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach
- (2018) Thais Guimarães Martins Nery et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
- (2017) Jesper F. Havelund et al. JOURNAL OF NEUROCHEMISTRY
- Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
- (2017) Jean-Pierre Trezzi et al. MOVEMENT DISORDERS
- metabolic profiling of Parkinson's disease and mild cognitive impairment
- (2017) Florence Burté et al. MOVEMENT DISORDERS
- Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis
- (2017) Marcel P. Stoop et al. Proteomics Clinical Applications
- Lipidomics in translational research and the clinical significance of lipid-based biomarkers
- (2017) Daniel J. Stephenson et al. Translational Research
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Translational Pharmacology
- (2017) Alastair G. Stewart Frontiers in Pharmacology
- Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
- (2017) Rose Ann Huynh et al. Frontiers in Neurology
- Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
- (2016) A. D. Andersen et al. ACTA NEUROLOGICA SCANDINAVICA
- Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels
- (2016) Henry H. Ruiz et al. Alzheimers & Dementia
- The Differential Diagnosis and Treatment of Atypical Parkinsonism
- (2016) Johannes Levin et al. Deutsches Arzteblatt International
- Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine
- (2016) Michel Frédérich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges of modifying disease progression in prediagnostic Parkinson's disease
- (2016) David Salat et al. LANCET NEUROLOGY
- NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects
- (2016) Junfang Wu et al. Metabolomics
- Metabolomics enables precision medicine: “A White Paper, Community Perspective”
- (2016) Richard D. Beger et al. Metabolomics
- Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy
- (2016) Vasudev Kantae et al. Metabolomics
- Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
- (2016) Anna Wuolikainen et al. Molecular BioSystems
- Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins
- (2016) Steffen Halbgebauer et al. MOVEMENT DISORDERS
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- Neurodegenerative diseases
- (2016) Marie-Thérèse Heemels NATURE
- The road to restoring neural circuits for the treatment of Alzheimer's disease
- (2016) Rebecca G. Canter et al. NATURE
- Ageing, neurodegeneration and brain rejuvenation
- (2016) Tony Wyss-Coray NATURE
- Defects in trafficking bridge Parkinson's disease pathology and genetics
- (2016) Asa Abeliovich et al. NATURE
- Accuracy of clinical diagnosis of Parkinson disease
- (2016) Giovanni Rizzo et al. NEUROLOGY
- The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
- (2016) Hugo Juárez Olguín et al. Oxidative Medicine and Cellular Longevity
- Epidemiology of Parkinson's disease
- (2016) A. Elbaz et al. REVUE NEUROLOGIQUE
- Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study
- (2015) Bernard Ravina et al. Biomarkers in Medicine
- Lipidomics applications for disease biomarker discovery in mammal models
- (2015) Ying-Yong Zhao et al. Biomarkers in Medicine
- Recent advances in biomarkers for Parkinson’s disease focusing on biochemicals, omics and neuroimaging
- (2015) Rutong Ren et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Advances in Biomarker Research in Parkinson’s Disease
- (2015) Shyamal H. Mehta et al. Current Neurology and Neuroscience Reports
- Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders
- (2015) Sumit Sethi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
- (2015) Javier Pagonabarraga et al. LANCET NEUROLOGY
- Biomarkers of Parkinson’s disease: Present and future
- (2015) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation
- (2015) Neha Sharma et al. NEUROCHEMISTRY INTERNATIONAL
- Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson’s disease
- (2015) Hemi Luan et al. Scientific Reports
- Balance Dysfunction in Parkinson’s Disease
- (2015) Steno Rinalduzzi et al. Biomed Research International
- Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
- (2014) Amy Reeve et al. AGEING RESEARCH REVIEWS
- Neuroimaging biomarkers for Parkinson disease: Facts and fantasy
- (2014) Joel S. Perlmutter et al. ANNALS OF NEUROLOGY
- Recent advances in metabolomics in neurological disease, and future perspectives
- (2013) Ai-hua Zhang et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Autophagy and apoptosis dysfunction in neurodegenerative disorders
- (2013) Saeid Ghavami et al. PROGRESS IN NEUROBIOLOGY
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- New Opportunities from the Cancer Metabolome
- (2012) O. A. Aboud et al. CLINICAL CHEMISTRY
- Global metabolic profiling of animal and human tissues via UPLC-MS
- (2012) Elizabeth J Want et al. Nature Protocols
- Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
- (2011) Warwick B Dunn et al. Nature Protocols
- What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
- (2011) Olga Corti et al. PHYSIOLOGICAL REVIEWS
- The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development
- (2010) Xiang-Qing Yu et al. Future Medicinal Chemistry
- Global metabolic profiling procedures for urine using UPLC–MS
- (2010) Elizabeth J Want et al. Nature Protocols
- Well-Water Consumption and Parkinson’s Disease in Rural California
- (2009) Nicole M. Gatto et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
- (2009) Marlon P. Quinones et al. NEUROBIOLOGY OF DISEASE
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
- (2008) Dana B Hancock et al. BMC Neurology
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Metabolomics-based methods for early disease diagnostics
- (2008) GA Nagana Gowda et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Metabolomic analysis of urine and serum in Parkinson’s disease
- (2008) Andrew W. Michell et al. Metabolomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started